Security key
28617K101
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 18,485,827
- Total 13F value
- $46,028,922
- Share change
- +165,229
- SEC-reported price per share
- $2.49
- Number of holders
- 33
- Value change
- +$410,879
- Number of buys
- 11
- Number of sells
- 6
- Shares outstanding
- 78,762,953
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
33
Top holders
10
ELDN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Eledon Pharmaceuticals, Inc. SEC filings
Eledon Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28617K101
Recent filing periods:
Ownership snapshot
Top reported holders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 8%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
8%
ARMISTICE CAPITAL, LLC
3%
Zimmer Partners, LP
2.7%
Schonfeld Strategic Advisors LLC
1.9%
SPHERA FUNDS MANAGEMENT LTD.
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
8%
|
$16,614,264
6,293,282 shares
|
— | 30 Jun 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
3%
|
$6,167,040
2,336,000 shares
|
— | 30 Jun 2024 |
| Zimmer Partners, LP |
13F
Company
|
2.7%
|
$5,569,619
2,109,704 shares
|
— | 30 Jun 2024 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
1.9%
|
$3,960,000
1,500,000 shares
|
— | 30 Jun 2024 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
1.6%
|
$3,424,135
1,297,021 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.4%
|
$2,915,603
1,104,395 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
18,485,827
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
31
Q3 2024 holders
33
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend